Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.
Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe publication details of the IOLite trial have been updated, with a change in the title formatting and the removal of a redundant description from PubMed.SummaryDifference1%
- Check13 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information in various formats have been removed.SummaryDifference0.7%
- Check20 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference0.7%
- Check35 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
- Check42 days agoChange DetectedA new publication has been added detailing a Phase Ib trial of the PD-1 inhibitor Dostarlimab in combination with other treatments for advanced cancer, while the previous revision (v2.11.2) has been removed.SummaryDifference1%
- Check64 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.